Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
Journal: The New England journal of medicine
Published: May 18, 2026
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study.
Journal: Therapeutic advances in respiratory disease
Published: November 08, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: June 06, 2024
Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis.
Journal: BMC pulmonary medicine
Published: October 16, 2023
Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.
Journal: BMJ open respiratory research
Published: December 23, 2022
Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis.
Journal: Clinical therapeutics
Published: December 21, 2022
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
Journal: American journal of respiratory and critical care medicine
Published: July 30, 2020
A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Pulmonary therapy
Published: April 29, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.
Journal: The Lancet. Respiratory medicine
Published: September 12, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026